Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

N/ANot Yet RecruitingNCT06510829

Assiut University30 enrolled

Overview

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to : * Clinically based on Change in the Size and Color of Hemangioma. * Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology . * Comparison of Complications associated with Bleomycin and Diode Laser.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Bleomycin Adverse Reaction

Interventions

Diode laserDEVICE

Application of laser waves on the lesion

Eligibility

Sex: ALLMin age: 3 MonthsMax age: 12 MonthsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 3 Months and 1 Year old. * Non Complicated Infantile Hemangioma Exclusion Criteria: * Younger than 3 Months or older than 1 Year. * Complicated Infantile Hemangioma

Outcomes

Primary Outcomes

Effect of diode laser on hemangioma

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.